Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02102100 · ClinicalTrials.gov registry record · NA
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT02102100 is a NA study that has completed, run by Yale University. The registered enrollment target is 57 participants.
The verdict
NCT02102100, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
This study will help determine if menthol administered by inhalation via electronic cigarettes (e-cigarette) changes the reinforcing effects of pure nicotine administered intravenously in cigarette smokers who smoke mentholated or non-mentholated cigarettes.
Interventions
- DRUG nicotine
- DRUG menthol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2014-03-26 |
| Est. Completion | 2016-07-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02102100
The ClinicalTrials.gov registry entry for NCT02102100 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nicotine is the first listed.
NCT02102100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02102100 about?
NCT02102100 is a clinical study titled "The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users". This study will help determine if menthol administered by inhalation via electronic cigarettes (e-cigarette) changes the reinforcing effects of pure nicotine administered intravenously in cigarette smokers who smoke mentholated or non-mentholated cigarettes.
What is the current status of trial NCT02102100?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2014-03-26. Estimated completion is 2016-07-11.
What interventions are being tested in trial NCT02102100?
The interventions under investigation include: nicotine (DRUG), menthol (DRUG).
Who is sponsoring clinical trial NCT02102100?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.